30 completed, 18 recruiting, 17 unknown, 10 terminated. 27 Not applicable, 20 Phase 2, 18 Phase 1, 4 Phase 3, 4 Phase 4.
Follow Gastric Outlet Obstruction: new trials by email Literature Review of Gastric Outlet Obstruction trials Research Report on Gastric Outlet Obstruction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Axatilimab + CAR-T for High-Risk Lymphoma Axatilimab - Diffuse Large B Cell Lymphoma (DLBCL), Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma | Phase 1 | Not yet recruiting | Northside Hospital, Inc. | 29 | 2026-12-31 | 2026-10-16 |
| Stomach-Partitioning Versus Conventional Gastrojejunostomy for Malignant Gastric Outlet Obstruction: A Multicenter Randomized Controlled Trial stomach-partitioning gastrojejunostomy, conventional gastrojejunostomy - Gastric Cancer, Gastric Outlet Obstruction | Not applicable | Not yet recruiting | Guangxi Medical University | 80 | 2026-10-20 | 2026-10-15 |
| Magnet System Gastric Outlet Obstruction Study Magnet System - Gastric Outlet Obstruction | Not applicable | Recruiting | GT Metabolic Solutions, Inc. | 10 | 2026-09-09 | 2026-09-14 |
| Malignant Gastric Outlet Obstruction Study With Stomach Partitioning (GO-PART) Conventional Gastrojejunostomy, Stomach-Partitioning - Stomach Neoplasms, Gastric Outlet Obstruction | Not applicable | Recruiting | Gyeongsang National University Hospital | 144 | 2026-08-01 | 2026-08-11 |
| Imaging Study of [89Zr]DFO-YS5 for Cancer Detection [89Zr]DFO-YS5, Positron Emission Tomography (PET)-Computerized tomography (CT) - Bladder Cancer, Nerve Sheath Tumor | Phase 1 | Recruiting | Robert Flavell, MD, PhD | 40 | 2026-06-15 | 2026-10-01 |
| Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer Telemedicine, Genetic Testing, Internet-Based Intervention - Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos | Not applicable | Recruiting | Alliance for Clinical Trials in Oncology | 535 | 2025-12-10 | 2026-10-02 |
| GT Metabolic Magnet System in Adults With Gastrointestinal Disorders Magnet System - Gastric Outlet Obstruction, Small Bowel Obstruction | Not applicable | Recruiting | GT Metabolic Solutions, Inc. | 35 | 2025-12-09 | 2026-05-19 |
| Existential Distress in Advanced Cancer: Comparing a Short-term Psychodynamic Psychotherapy (ORPHYS) to Treatment as Usual (TAU) ORPHYS (ShORt-term psychodynamic psychotherapy in serious PHYSical illness), TAU (Treatment As Usual: Standard psycho-oncological care) - Advanced Cancer, Various, NOS | Not applicable | Recruiting | Universitätsklinikum Hamburg-Eppendorf | 160 | 2025-10-24 | 2025-12-31 |
| Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation Cytarabine IT, hydrocortisone, Cisplatin - CNS Embryonal Tumor, CNS, Medulloblastoma | Early Phase 1 | Recruiting | C17 Council | 15 | 2025-09-23 | 2026-07-14 |
| Novel Balloon-Assisted vs Direct Technique in EUS-Guided Gastroenterostomy a novel balloon-assisted EUS-GE, direct EUS-GE - Gastric Outlet Obstruction | Not applicable | Not yet recruiting | Changhai Hospital | 272 | 2025-09-01 | 2025-09-09 |
| Brentuximab Vedotin Combined With R-CHP in Newly Diagnosed EBV+ DLBCL-NOS BV+R-CHP - EBV-Positive Diffuse Large B-Cell Lymphoma, Nos, Brentuximab Vedotin | Phase 2 | Not yet recruiting | The First Affiliated Hospital with Nanjing Medical University | 25 | 2025-09-01 | 2025-09-30 |
| Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations Venetoclax, Azacitidine, Cytarabine - Early T Acute Lymphoblastic Leukemia, T-Acute Lymphoblastic Leukemia | Phase 2 | Recruiting | yuejun Liu | 32 | 2025-04-01 | 2025-06-10 |
| Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma C402-CD19-CAR - Diffuse Large B-cell-lymphoma, DLBCL, Nos Genetic Subtypes | Phase 1 | Recruiting | Shanghai Exuma Biotechnology Ltd. | 18 | 2025-03-25 | 2026-09-11 |
| Embryonal Tumor With Multilayered Rosettes Radiotherapy (RT), Chemotherapy Drug, Cancer - Physician's Choice, Non-Investigational Surgical Resection - Embryonal Tumor With Multilayered Rosettes, Embryonal Tumor With Multilayered Rosettes, Nos | Phase 2 | Recruiting | University of California, San Francisco | 70 | 2025-03-06 | 2026-06-29 |
| AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE AXIOS(TM) Stent and Electrocautery Enhanced Delivery System - Gastric Outlet Obstruction | Not applicable | Suspended | Boston Scientific Corporation | 67 | 2025-02-11 | 2026-10-07 |
| SynKIR-310 for Relapsed/Refractory B-NHL SynKIR-310 - B Cell Lymphoma, NHL, Adult | Phase 1 | Recruiting | Verismo Therapeutics | 36 | 2024-11-01 | 2026-04-14 |
| Management of Malignant Gastric Outlet Obstruction Between Surgery and Endoscopy Gastric Outlet Obstruction, Pancreatic Cancer | Recruiting | IRCCS San Raffaele | 250 | 2024-04-15 | 2026-01-15 | |
| Study of SGR-1505 in Mature B-Cell Neoplasms SGR-1505 - Mature B-Cell Neoplasm, Non Hodgkin Lymphoma | Phase 1 | Recruiting | Schrödinger, Inc. | 98 | 2023-04-10 | 2026-02-13 |
| Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas ACALABRUTINIB, LISOCABTAGENE MARALEUCEL, Lymphodepleting chemotherapy - Refractory Aggressive B-cell Lymphomas, Refractory B-Cell Non-Hodgkin Lymphoma | Phase 2 | Active not recruiting | Patrick C. Johnson, MD | 28 | 2023-03-01 | 2026-01-29 |
| Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass The Hot AXIOS™ Stent and Electrocautery-Enhanced Delivery System - Hypoglycemia, Gastric Outlet Obstruction | Not applicable | Recruiting | University Hospital, Ghent | 20 | 2023-01-30 | 2025-10-08 |
Showing 20 of 84. Sign in to see all of them.
Pyloric Stenosis, Hypertrophic (49) · Pyloric Stenosis (9) · Lymphoma, Large B-Cell, Diffuse (8) · Lymphoma, Follicular (5) · Neoplasms (5) · Lymphoma, B-Cell (4) · Stomach Neoplasms (4) · Lymphoma, B-Cell, Marginal Zone (3) · Lymphoma, Mantle-Cell (3) · Lymphoma, Non-Hodgkin (3) · Neuroectodermal Tumors, Primitive (3) · Recurrence (3) · Waldenstrom Macroglobulinemia (3) · Astrocytoma (2)
Digestive System Diseases (84) · Stomach Diseases (84) · Gastrointestinal Diseases (83) · Pyloric Stenosis (48) · Neoplasms (23) · Neoplasms by Histologic Type (19) · Pathological Conditions, Signs and Symptoms (18) · Immune System Diseases (15) · Hemic and Lymphatic Diseases (13) · Pathologic Processes (13) · Immunoproliferative Disorders (12) · Lymphatic Diseases (12) · Lymphoproliferative Disorders (12) · Lymphoma (11)
Cyclophosphamide (5) · Lenalidomide (4) · Vincristine (4) · Doxorubicin (3) · Rituximab (3) · Filgrastim (2) · Granulocyte Colony-Stimulating Factor (2) · Prednisolone (2) · R-CHOP protocol (2) · Temozolomide (2) · tislelizumab (2) · 4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo(1,2-f)(1,2,4)triazine-6-carboxamide (1) · Acetaminophen (1) · Anesthesia, General (1) · Anesthesia, Spinal (1)
Bristol-Myers Squibb (4) · Huiqiang Huang (3) · The First Affiliated Hospital with Nanjing Medical University (3) · Alliance for Clinical Trials in Oncology (2) · Boston Scientific Corporation (2) · Children's Mercy Hospital Kansas City (2) · Chinese University of Hong Kong (2) · Cook Group Incorporated (2) · GT Metabolic Solutions, Inc. (2) · Memorial Sloan Kettering Cancer Center (2) · Xencor, Inc. (2) · Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University (1) · Ajou University School of Medicine (1) · Arlyne Thung (1) · Astex Pharmaceuticals, Inc. (1)
United States (35) · China (15) · Canada (13) · France (13) · Italy (11) · South Korea (7) · Spain (7) · United Kingdom (5) · Australia (4) · Czechia (4) · Germany (4) · India (4) · Belgium (3) · Hong Kong (3) · Netherlands (3)
Wei Xu, M.D., Ph.D. (2) · Alan Ho, MD (1) · Angela Bradbury, MD (1) · Annie Huang (1) · Beth Loveridge-Lenza, DO (1) · Chet Bohac, PharmD, MD, MSc (1) · Connor Johnson, MD (1) · Daniel J Ostlie, MD (1) · Darrel P Cohen, MD, PhD (1) · Derek Hanson, MD (1) · Ding Shi (1) · Dr. Helene Flageole, MD, FRCSC (1) · Dr. Peter Metrakos, MD (1)
PMID 19155060, PMID 20925534, PMID 22480835, PMID 23932009, PMID 25783381, PMID 27012778, PMID 28153605, PMID 28478586, PMID 28576557, PMID 28793993, PMID 28982258, PMID 29722835, PMID 30480549, PMID 31325010, PMID 31744509, PMID 32756081, PMID 33422612, PMID 34049362, PMID 35065786, PMID 35398840, PMID 35867947, PMID 35947304, PMID 35997700, PMID 36801458, PMID 36918264, PMID 37325351, PMID 37530631, PMID 37827868, PMID 38061378, PMID 38182653, PMID 38218194, PMID 38636983, PMID 39377069, PMID 40347959, PMID 40998416, PMID 41548724, PMID 41577578, PMID 41584027, PMID 41820242, PMID 42098804
2009 (1), 2016 (1), UM1CA081457 (1)